Full-Time

Senior AI Applied Scientist 2

Prenuvo

Prenuvo

201-500 employees

Whole-body MRI for early disease detection

Compensation Overview

CA$150k - CA$177k/yr

Vancouver, BC, Canada

Hybrid

Hybrid role based in Vancouver, BC; on-site presence in Vancouver may be required.

Master's, PhD

Category
AI & Machine Learning (2)
,
Required Skills
LLM
PyTorch

Get referred to Prenuvo

See people who can refer or advise you

Requirements
  • Strong MSc or PhD from a top-tier institution in CS, biomedical engineering, statistics, mathematics, or a related field.
  • A minimum of 4 academic or industry years of ML experience, with a strong publication or applied-research record including at least one first-author work.
  • Expert-level PyTorch and the ability to write and review production-quality research code.
  • Demonstrated ability to own a model domain end-to-end (architecting, training, validating, deploying to a real performance bar) and to design experiments and validation studies independently.
  • Deep fluency in self-supervised learning: masked image modeling, contrastive learning, JEPA-style methods, knowledge distillation, and large-scale representation learning.
  • Strong command of modern vision and multimodal architectures: Vision Transformers, multimodal transformers, foundation models, and vision-language models.
  • Experience in medical image analysis (segmentation, detection, classification, biomarker extraction, longitudinal modeling) and multimodal fusion of imaging with radiology, clinical, lab, and structured patient data.
  • Experience applying generative and agentic AI (LLM adaptation, workflow orchestration) to healthcare or research applications.
  • Strong collaboration skills across ML Engineering, Product, and Clinical Ops, with high standards for scientific rigor balanced against delivery speed.
Responsibilities
  • Lead development of foundation models and multimodal systems for whole-body MRI, advancing self-supervised and large-scale representation learning across imaging, radiology, lab, and longitudinal data.
  • Own experiment design and validation study scoping for your domain, diagnosing failure modes independently.
  • Drive the data quality, annotation criteria, and quality standards your models depend on, engaging directly with clinical framing for your domain.
  • Guide the strategic application of generative and agentic AI, including LLM adaptation and workflow orchestration, to accelerate research and clinical workflows.
  • Contribute modeling approaches that others adopt, and define and execute a research roadmap that advances Prenuvo's foundation-model capabilities.
  • Lead clinical review for your domain, partner across clinical, annotation, and ML Engineering, and raise the code-quality bar for the team.
  • Deliver production-ready models with documented validation, clinical sign-off, and performance benchmarks, owning the technical narrative for your domain.
Desired Qualifications
  • Experience in body composition, vascular imaging, organ segmentation, or lesion detection
  • Familiarity with FDA 510(k) submission processes or predicate-based regulatory pathways
  • Publications in top journals and conferences such as ISMRM, NeurIPS, MICCAI, ICML, RSNA, etc.
  • Experience with interpretable AI and state-of-the-art AI methods
  • Prior work in a health tech or clinical AI environment

Prenuvo provides whole-body MRI scans to help detect over 500 cancers and diseases early. The MRI is radiation-free, non-invasive, takes under an hour, and does not use contrast agents. Customers book online and visit Prenuvo’s scanning centers for a session, paying per scan or via a subscription plan. The scans are designed for proactive health monitoring, especially for health-conscious individuals or those with a family history of disease. The service operates in the preventive medicine and diagnostic imaging space and sells direct-to-consumer scanning services. The goal is to shift healthcare from waiting for symptoms to early detection, which can lead to less invasive treatments and lower long-term costs by catching diseases early.

Company Size

201-500

Company Stage

Series B

Total Funding

$190M

Headquarters

Redwood City, California

Founded

2018

Get referred to Prenuvo

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • EHE Health partnered with Prenuvo on July 30, 2026, expanding employer access.
  • Prenuvo added standalone heart and brain scans July 20, 2026, widening monetization.
  • Polaris findings presented at AACR 2025 support clinical credibility and insurer negotiations.

What critics are saying

  • Sean Clifford sued Prenuvo in September 2024; Washington Post covered it January 2026.
  • Whole-body MRI finds incidental abnormalities, driving follow-up costs and trust erosion after false positives.
  • Insurance noncoverage keeps pricing cash-pay; if employer adoption stalls, growth stays niche.

What makes Prenuvo unique

  • Prenuvo operates 26 clinics, combining whole-body MRI with radiology, software, and lab interpretation.
  • Its March 2026 memberships bundle scans, bloodwork, brain health, and body composition.
  • The platform’s 170,000-plus scans create proprietary screening data competitors lack.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Mental Health Support

Unlimited Paid Time Off

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

0%

2 year growth

6%
DistilInfo
Jul 31st, 2026
Function Health nets $450M for preventive care.

Function Health nets $450M for preventive care. Table of contents. More than 100 million Americans do not have a primary care doctor. For those who do, the average wait for an appointment now stretches to 31 days. Three in four U.S. adults are managing at least one chronic condition, and 90% of the United States' $4.9 trillion in annual healthcare spending goes toward treating diseases that are often detectable years before symptoms appear. Function, the Austin-based health-testing platform, wants to prove there's a cheaper argument to be had, backed now by a substantial Function Health General Catalyst funding round. The scale of this Function Health General Catalyst funding deal. Function has secured $450 million in growth financing from General Catalyst's Customer Value Fund, the venture firm's non-dilutive vehicle that ties capital to customer growth rather than equity. It is one of CVF's largest deals to date, following a similar $200 million commitment to healthcare AI platform Commure in June 2025. What Function's platform actually offers. Founded in 2021 by Jonathan Swerdlin, Pranitha Patil, Dr. Mark Hyman, Seth Weisfeld, Mike Nemke, and Dan Swerdlin, Function combines more than 160 lab tests, roughly five times what a standard annual physical covers, with advanced imaging designed to catch early signs of cancer, aneurysms, stroke, and hundreds of other conditions, all inside a single annual membership priced at $365, or a dollar a day. Function's growth since launch. Since launching its beta in 2023, the company says it has grown to more than 500,000 members and completed over 100 million lab tests, according to the company. "Our mission is simple: enable you to live 100 healthy years. Everyone deserves to feel their best and avoid suffering. This growth financing allows us to bring that future of health into the present," said Swerdlin, Function's co-founder and chief executive. Recent acquisitions behind this Function Health General Catalyst funding. The financing landed months after two acquisitions that filled out Function's platform: Getlabs, which brought nationwide at-home and office blood draws, and SuppCo, whose TrustScore system rates the reliability of over-the-counter supplements. Neither deal disclosed terms. Function also acquired MRI scanning platform Ezra in May 2025, giving it a nationwide scanning network now covering more than 200 locations. A crowded preventive health field. Function is far from alone in pursuing the idea that AI and continuous monitoring can catch disease before it starts. Neko Health, co-founded by Spotify's Daniel Ek, closed a $700 million Series C at nearly $7 billion in July 2026 to build its own scanning hardware and enter the U.S. Superpower raised $30 million at a $300 million-plus valuation using partner labs rather than owning the testing infrastructure, while Prenuvo has leaned entirely on whole-body MRI, generating roughly $250 million in annual revenue off $192 million raised. Function's bundled approach as a differentiator. Where those rivals specialize in one layer, such as imaging, labs, or software, Function combines labs, imaging, at-home draws and supplement guidance into a single membership, wagering that bundling wins out over point solutions. European competitors chasing the same thesis. European challengers are chasing the same thesis at a fraction of the capital. Paris-based Lucis, also backed by General Catalyst, raised $8.5 million to bring biomarker tracking to Europe, while Swiss startup Ahead Health raised $10 million to combine blood panels and MRI for launches in Germany and the Netherlands. UK's Numan has taken a different route into the same market, reporting $90 million in 2024 revenue from personalized preventive care. A stark capital intensity gap. Next to Function's $450 million non-dilutive cheque, the gap in capital intensity between the U.S. and European versions of the same idea is stark. "Function has created an entirely new approach to health. We believe the company is uniquely positioned to reach millions more people, and we're proud to support its next phase of growth," said Pranav Singhvi, partner and co-head of CVF at General Catalyst. What this Function Health General Catalyst funding structure means. Because CVF financing is structured as non-dilutive, revenue-linked capital rather than an equity stake, this deal does not reset Function's valuation, which stood at $2.5 billion after a $298 million Series B in November 2025 led by Redpoint Ventures, with participation from a16z, Aglaé Ventures, Battery Ventures, NFDG, and Roku founder Anthony Wood. Combined with roughly $350 million raised in prior equity rounds, Function has now raised more than $800 million across equity and non-dilutive financing. A growing market backdrop. According to Grand View Research, the global preventive healthcare technology market is expanding as diagnostics and AI push care earlier into a person's life, rather than after symptoms appear. Whether preventive testing becomes a genuine category of healthcare or a subscription for the worried wealthy is still unsettled. Function's membership costs a fraction of Neko's per-visit pricing, but at $365 a year with no insurance involved, the "millions more people" Singhvi describes will need convincing that data bought out of pocket is worth more than a doctor they cannot see. What to watch going forward. As Function deploys this Function Health General Catalyst funding to expand its bundled testing, imaging, and supplement platform, industry observers will likely watch whether the company's all-in-one approach proves more durable than the specialized, single-layer strategies pursued by Neko Health, Prenuvo, and Superpower. Given the significant capital gap between U.S. and European preventive health startups pursuing similar theses, how Function scales beyond its current 500,000 members may offer an important signal for whether consumer-paid preventive testing can become a mainstream category or remains a niche offering for those able to pay out of pocket.

PR Newswire
Jul 30th, 2026
Advancing prevention: EHE Health & Prenuvo partner to integrate whole-body MRI into proactive care.

Advancing prevention: EHE Health & Prenuvo partner to integrate whole-body MRI into proactive care. Jul 30, 2026, 10:00 ET NEW YORK, July 30, 2026 /PRNewswire/ - EHE Health, the nation's leading preventive healthcare provider, today announced a new partnership with Prenuvo, the leader in proactive whole body MRI screening. This partnership solidifies the shared mission of making proactive health screenings more accessible and central to preventive care. Prenuvo provides a non-invasive MRI that screens for hundreds of conditions across 33 organs in a single session. It's designed to help identify conditions like tumors, aneurysms, many cancers sometimes as early as stage 1, organ disease, and other structural changes in the body - often before symptoms appear. Executive and self-pay members will have access to the Prenuvo Whole Body Scan at an exclusive $400 discount. Members will be able to access the discount via a QR code after completing an EHE Health exam. After completing a scan, patients can access their report in the Prenuvo App or Dashboard and schedule a Prenuvo Results Review Appointment to review findings with a Prenuvo provider. Using spacious, open-bore MRI scanners, Prenuvo's Whole Body Screening is fast (under 1 hour), safe (no harmful radiation), and non-invasive (no contrast). The scan can help identify many cancers, sometimes as early as stage 1, aneurysms, and hundreds of other conditions, including metabolic and neurological diseases. "Our partnership with Prenuvo strengthens our commitment to helping people take a more proactive approach to their health," said Dr. Neal Mills, Chief Medical Officer at EHE Health. "It's another way we're empowering individuals with early detection, informed decision-making, and high-quality preventive options." This partnership allows members to conveniently complete both their annual exam and a Prenuvo Scan close to home or on the road, with clinics available in major cities across the U.S. "Early detection only matters if it's accessible and meaningful," said Andrew Lacy, founder and CEO of Prenuvo. "This partnership with EHE Health allows us to deliver meaningful insights that can support ongoing health awareness and more informed conversations with healthcare providers." Select EHE Health members can now access their Prenuvo discount. To learn more about Prenuvo benefits for EHE Health members, visit www.prenuvo.com. About EHE Health EHE Health is a national preventive healthcare provider network that partners with mid- and large-sized employers to give their employees and beneficiaries an entry point to organized healthcare, beginning with prevention. Named by Fortune Magazine and Great Place to Work(R) as one of the Best Workplaces in healthcare, EHE Health is headquartered in New York City and has over 200 health clinics across the U.S., staffed by a network of curated primary care physicians and clinicians. For over 100 years, EHE Health has been an innovator and leader in helping people live longer, healthier lives with personalized preventive care. For more information, visit us at www.ehe.health. About Prenuvo Prenuvo makes proactive health screening seamless and more widely accessible. Combining high-quality technology with radiation-free and non-invasive imaging assessments, Prenuvo's patient-centric design is optimized to assess the body holistically, providing individuals with a detailed overview of their health. Prenuvo's exclusively-affiliated Radiology group partners consist of 100+ radiologists who help risk-stratify each patient report, keeping in mind healthcare complexities from the patient's perspective, the treating clinician's perspective, and the healthcare system's perspective. Prenuvo currently operates in 26 clinics across North America, Australia, and Europe. To find your nearest Prenuvo, please visit here. Learn more at www.prenuvo.com and connect with Prenuvo here. SOURCE EHE Health

PR Newswire
Mar 23rd, 2026
Prenuvo launches membership programme for whole-body MRI screening from $1,199 annually

Prenuvo, a whole-body MRI screening company, has launched a membership programme offering year-over-year health monitoring through standardised scanning protocols. The company, which has completed over 170,000 scans, operates 26 clinics across North America, Australia and Europe. The programme features three tiers: Core Membership at $1,199 annually includes a focused scan and lab panel; Comprehensive Membership at $2,499 pairs a whole-body scan with detailed lab work; and Executive Membership at $4,499 adds brain health assessment and body composition analysis. Prenuvo emphasises its vertically integrated approach, controlling equipment, software and radiology interpretation through board-certified radiologists specialising in preventive screening. The company's 60-minute whole-body scan generates over 1.3 billion data points to detect potential conditions across major body systems without radiation or contrast agents.

USA Today
Mar 23rd, 2026
Exclusive: Prenuvo expands full-body MRI protocol. What's new?

Exclusive: Prenuvo expands full-body MRI protocol. What's new? Updated March 23, 2026, 4:19 p.m. ET Deeper Dive BETA Which other companies offer full-body MRI services? What biomarkers does the Prenuvo blood panel assess? Which other companies offer full-body MRI services? Who is the founder and CEO of Prenuvo? AI Overview Full Summary Prenuvo has added a blood-work component to its full-body MRI service and introduced three tiered membership plans that combine scans with laboratory panels, positioning the offering as a complementary preventive health tool. BETHESDA, MD - Beep. Beep. Beep. The whole-body MRI machines whir, in conversation with the skeleton staring back at me on the computer screen. On a gray March afternoon, a technician highlights specific parts of a patient's anatomy, each part generating unique pitches and rhythms. This individual's brain - their hippocampus, specifically - looks like a tree, arteries stretching out like branches. Once finished, this Prenuvo scan will give this patient and their health care providers 1.3 billion data points about their health. You read that right: 1.3 billion. "We've really designed something to get the most information possible across lots of different organ systems and to be able to detect all sorts of things that you want to know about in advance," says Dr. Daniel Durand, Prenuvo's chief medical officer, sporting a smart watch on his wrist. The company says it finds possibly life-threatening conditions in 1 in 20 people. And it's poised to now offer even more data. Prenuvo is launching a new bloodwork component to complement its full-body MRI offerings as part of a new membership package. It's not raising its prices, just adding laboratory assessments that evaluate biomarkers related to inflammation, cardiovascular risk, hormone balance and more. Prenuvo reiterates it views itself as complementary to primary care and doesn't advocate anyone skipping routine doctor's appointments. "Today, we don't replace primary care," Durand says. "We don't replace these other tests, we add to them. But in the future, what we're trying to do is make it so that you get this holistically, in one setting, in a really pleasant way, because that's what's going to make people want to come back." What Prenuvo's new membership tiers look like. If you're looking to get a Prenuvo scan, here's what to expect now. * Core Membership. Cost: $1,199 annually. This includes a focused scan - a quicker, 30-minute MRI that examines your head to your mid-thigh - plus a blood panel assessment to get a general sense of where your health is. * Comprehensive Membership. Cost: $2,499 annually. This includes a whole-body scan and more detailed lab panels, like metabolic, cardiovascular, hormonal and inflammatory biomarkers. * Executive Membership: Cost: $3,999 annually but $4,499 in New York. This is the company's most in-depth option. You get a whole-body scan, brain health assessment, body composition analysis and an extra-detailed lab panel. It will offer insights on your reproductive hormones, metabolic markers, nutrient levels and systemic inflammation. If you just want to get a scan and skip the bloodwork, that's an option too, though you'll be paying the same price. We only widely screen for five cancers in the United States: breast, colorectal, prostate, cervical and lung cancer, the latter solely in high-risk patients. Such screenings prevent deaths, but in Durand's mind - and where Prenuvo comes into play - "It's not just enough to have science. You have to think through experience. You have to think through engagement." The future of screening technology isn't scanning organ by organ and dozens of appointments, but more of a one-stop shop. Preventative medicine providers and radiologists will work together to give the patient an accurate, detailed picture of their health with results from both the MRIs and bloodwork. These consults will focus on "what are the really salient things that this person can do to improve their health," Durand says. Prenuvo recommends annual scans for most patients, but some may be asked to come in sooner depending on conditions they watch for/will send them along for additional screenings. In patients younger than 40 without anything even remotely suspicious to monitor - a rarity - they may return every two years. Who is Prenuvo's target market exactly? People who are healthy right now and want to know as much about their body as possible - think Oura ring users. Another market is the "worried well," or customers that skew older and seek out early detection for diseases. They may also flock to liquid biopsy tests like Galleri for multi-cancer early detection. Patients may experience sticker shock at Prenuvo's pricing. But "uniquely in health care, we tell you what our test costs. So there aren't surprises," Durand says. Still, if the tests find something that requires additional diagnostics, you end up in the murkier-pricing health care system anyway. The average out-of-pocket health care cost is $1,632 per person in the U.S., not counting health insurance premiums, according to 2024 Kaiser Family Foundation figures. Insurance does not cover Prenuvo scans and therefore these tests come at an additional health care cost. 'We choose not to discard the information' Research shows full-body MRIs often find something, but much less often find actual disease. One study in 2020 found that 95% of asymptomatic patients had some type of "abnormal" finding, but just 1.8% of these findings were indeed cancer. Research has varied on just how many incidental findings occur from these tests. With 1.3 billion data points, Prenuvo is going to find things that aren't worth worrying about. It's a trade-off of getting a test that granular. If you take a CT scan of an elderly person, for example, there's a ton of information in there about aging blood vessels that gets discarded. Why worry about chronic disease when that's not something that's going to kill the patient, or the reason they came in? "We choose not to discard the information," Durand says. "We think all that information really, really matters. I think radiology is going that direction." It's important to note Prenuvo isn't the only full-body MRI company out there. Function and SimonMed are other options, and each touts benefits they feel sets them apart. Prenuvo has a number of clinical studies and trials in motion. One called Hercules is looking at 100,000 people based out of Boston and is evaluating the clinical performance of these scans and whether doing the scan has positively or negatively impacted their health. "I think that will create a higher evidentiary fact base for which we can have a conversation with insurers about coverage," says Andrew Lacy, founder and CEO of Prenuvo. He has friends who remain skeptical about getting the test done on themselves but many who appreciate it and plan to do annually. "If we change consumers' expectations about health care, that eventually sort of bleeds upstream to doctors and to employers," he says, giving him hope for a future where these procedures are covered. The history of medical screening in general, Durand says, bends toward looking for more earlier. That's true for the patient on the table in Bethesda, a returning Prenuvo client. "Best way to stay healthy," Durand quipped. This story has been updated with new information.

Prenuvo
Jan 8th, 2026
Baker Health partners with Prenuvo to elevate proactive health screening for members

Baker Health partners with Prenuvo to elevate proactive health screening for members. New York, NY - [January 8th, 2026] - Baker Health, a concierge primary care platform focused on personalized and integrative wellness, announced a new partnership with Prenuvo, the leader in whole body MRI for proactive health screening. This collaboration gives Baker Health Members streamlined access to Prenuvo's radiation-free, non-invasive whole-body MRI technology, providing comprehensive health insights designed to support proactive, personalized care. Prenuvo offers advanced screening services that include whole body MRI, an FDA-cleared AI-powered body composition analysis, brain health assessments, and functional and conventional blood biomarkers. In under 60 minutes, Prenuvo captures millions of data points, offering individuals a holistic view of their health through scans engineered for speed, accuracy, comfort, and safety. "At Baker Health, we are committed to giving our Members the most advanced tools to understand and optimize their health," said Dr. Iyad Baker, Co-Founder of Baker Health. "Partnering with Prenuvo enhances our ability to deliver personalized, proactive care and help support long-term wellness." "This partnership brings advanced imaging into an ongoing primary care relationship," said Andrew Lacy, founder and CEO of Prenuvo. "Prenuvo's whole body MRI gives Baker Health clinicians objective, whole body health insights that complement labs and clinical history, helping guide preventive conversations and long-term health planning." Prenuvo's technology and clinical partnerships support individuals and their healthcare teams with comprehensive insights that help contextualize health concerns clearly. With more than 150,000 scans completed and an exclusively-affiliated radiology group of over 100 board-certified radiologists, Prenuvo provides detailed whole body imaging designed to help identify various health abnormalities, including metabolic disorders, spinal degeneration, brain aneurysms, auto-immune disorders, solid tumors as early as stage 1, and non-cancerous conditions such as cysts, hematomas, and abscesses. Today, 1 in 20 Prenuvo scans results in a potentially life-saving diagnosis.* This partnership reinforces Baker Health's commitment to prevention-forward, relationship-driven medicine. By integrating Prenuvo's advanced imaging into Baker Health's tech-enabled, seamlessly connected ecosystem, Members gain access to a more comprehensive, proactive approach to optimizing their long-term health and well-being. *Disclaimer: Based on its internal data analysis, 5% of Prenuvo scans have helped detect a potentially life-saving condition. This reflects in particular the combined prevalence of radiologically-suspected pre-cancerous/cancerous-findings or CSD4+ as defined in its whole body MRI screening practice. About Baker Health Baker Health delivers concierge primary care focused on prevention, wellness, and lifestyle optimization. Combining personalized care with integrative services - including nutrition, mental health, weight management, and lifestyle medicine - Baker Health provides Members with a holistic, whole person approach to long-term health and longevity. Through extended visits, seamless access to doctors, and a curated specialty network, Baker Health ensures Members receive proactive guidance and actionable insights to optimize their well-being. Baker Health serves Members across multiple locations and provides a tech-enabled experience through the proprietary Baker Health app, offering 365-day access to doctors and care teams. About Prenuvo Prenuvo makes proactive health screening seamless and more widely accessible. Combining advanced technology with radiation-free and non-invasive whole body scans, Prenuvo's patient-centric design is optimized to assess the body holistically, providing individuals with a comprehensive overview of their health in under 60 minutes. Prenuvo's exclusively-affiliated Radiology group partners consist of 100+ radiologists who help risk-stratify each patient report, keeping in mind healthcare complexities from the patient's perspective, the treating clinician's perspective, and the healthcare system's perspective. Prenuvo clinics are currently open in New York, Buffalo, Redwood City, Los Angeles, Pasadena, Irvine, Dallas, Houston, Boca Raton, Chicago, Las Vegas, Bethesda (DC metro area), Atlanta, Vancouver, and Minneapolis. Learn more at www.prenuvo.com.